Inhaled creatine dry powder inhalation and preparation method thereof
Direct delivery of inhaled creatine powder atomizer to the lungs solves the problems of large doses and low bioavailability of oral creatine products, achieves faster onset and higher bioavailability, and passes multiple screenings The hybrid method simplifies production and improves the portability and production efficiency of the product.
Patent Information
- Application Number
- CN202411140109.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-29
AI Technical Summary
Existing creatine products are subject to large doses, low bioavailability and poor taste through oral administration, which is difficult to meet the needs of athletes and fitness students for quick supplementation and portability.
Inhaled creatine powder atomizer is used to deliver the drug directly to the lungs through inhalation administration, avoiding the first pass effect of the liver, and simplifying the production process with multiple screening mixing methods, providing portability and high bioavailability.
It realizes creatine supplementation with smaller dosage and faster onset of effects, avoids the first-pass effect of the liver, improves bioavailability and user experience, and simplifies the production process, which is suitable for small-scale production.
Smart Images

Figure CN119033738A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of inhalation drug administration, and relates to an inhalable creatine powder aerosol and a preparation method thereof. Background Art
[0002] Creatine is a nitrogen-containing organic acid that exists naturally in the human body, mainly in muscle tissues such as skeletal muscle and cardiac muscle. Creatine can increase the content of creatine phosphate in muscles, and creatine phosphate is the reserve form of ATP, the direct energy source required for muscle contraction. Therefore, supplementing creatine can improve the body's athletic ability, which is especially beneficial for sports that require explosive power.
[0003] As early as 1832, French chemist Michel Eugène Chevreul first isolated creatine from skeletal muscle. In the 1920s, scientists discovered that large doses of creatine were not excreted by the human body, indicating that the human body can store creatine. Subsequently, studies have found that the endogenous creatine content in muscle can be increased through exogenous supplementation, which laid the foundation for creatine as a dietary supplement.
[0004] Creatine became widely popular as a sports nutrition supplement in the early 1990s. In 1993, a company called EAS launched a high-purity creatine product, Phosphagen, specifically designed to enhance strength, marking the official entry of creatine into the sports nutrition supplement market.
[0005] Since then, a large number of studies have confirmed the effectiveness of creatine supplementation in improving athletic performance. A meta-analysis of 22 studies showed that creatine supplementation can significantly improve muscle strength and body weight after strength training. Another meta-analysis of 16 studies also came to a similar conclusion.
[0006] Creatine is not only beneficial to healthy people, but also has potential therapeutic effects in some disease populations. Studies have found that creatine supplementation can improve the motor and cognitive functions of patients with neurodegenerative diseases such as Parkinson's disease and Huntington's disease. In patients with heart failure, creatine supplementation can improve exercise endurance and improve quality of life. In addition, creatine has also been shown to have a certain auxiliary therapeutic effect on diseases such as type 2 diabetes and osteoporosis.
[0007] Although the safety and effectiveness of creatine supplements have been widely recognized, there are still some controversies. Some studies have suggested that long-term high-dose creatine supplementation may increase the burden on the kidneys and liver, but there is no definitive answer. In addition, because creatine increases the water content in the muscles, some athletes worry that this will affect their eligibility for weight-class events.
[0008] At present, the common way to supplement creatine is to take 3-5 grams of creatine monohydrate orally every day for several weeks. In order to further improve the absorption rate, some manufacturers have developed new creatine supplements such as creatine glucoside and creatine citrate, but their superiority still needs more research to confirm.
[0009] In general, as a safe, effective and inexpensive nutritional supplement, creatine is popular among athletes and fitness enthusiasts. However, individual differences are large, and not everyone can benefit from creatine supplementation. In addition, it is not advisable to rely solely on supplements and ignore training. Reasonable diet, scientific training, and appropriate nutritional supplements are the best way to improve athletic performance.
[0010] In the future, the research directions of creatine may focus on the following aspects: 1. Develop new creatine supplements with higher absorption rate and less side effects; 2. Further explore the therapeutic effects and mechanisms of creatine on various diseases; 3. Combine creatine with other nutrients to find the best combination; 4. Develop individualized supplementation plans, and tailor the supplementation dosage and cycle according to factors such as genotype, age, and sports. It is believed that through the joint efforts of the scientific and industrial communities, creatine supplements will play a greater role in improving human athletic ability and health levels. Summary of the invention
[0011] In order to solve the problems of existing oral creatine products such as large dosage, low bioavailability, and poor taste, the present invention provides an inhalable creatine powder spray and a preparation method thereof. Inhalation administration can quickly deliver the drug to the lungs, avoid the first-pass effect of the liver, achieve a blood drug concentration similar to oral administration at a lower dose, and have a faster onset time. Specifically, the improvement of the administration method
[0012] Traditional creatine products are mostly taken orally, with a large single dose. This product innovatively uses inhalation administration, which has the following advantages:
[0013] Inhalation administration has a smaller dosage and a faster onset of action. Inhalation administration allows the drug to be directly absorbed into the systemic circulation through the lungs, avoiding the first-pass effect of oral administration in the liver and achieving higher bioavailability.
[0014] Better compliance. Oral creatine products often have a bad taste, which affects the user experience. Inhaled creatine has almost no taste (only a small amount of sweetness), which makes it easier to use and stick to it.
[0015] Improved portability
[0016] Common creatine powders and granules are not convenient to carry and use, and need to be weighed and brewed. This product uses an inhalation preparation, which has the following advantages:
[0017] Small size, easy to carry around. Not restricted by usage environment, can be used at any time.
[0018] The operation is simple, just open the package and inhale as needed, no need to brew or dissolve.
[0019] Optimization of production process
[0020] Traditional low-content drug mixing usually uses a high shear mixer, which is expensive and has requirements for production scale. The present invention innovatively adopts a multiple sieving mixing method:
[0021] The required equipment is simple and easy to obtain, such as a vibrating screen, and the process is simple and easy.
[0022] It is suitable for small batch production, has high flexibility and is more suitable for laboratories and small-scale production.
[0023] Sieving and mixing can effectively avoid local aggregation of drugs and achieve high mixing uniformity.
[0024] In summary, this product has been systematically innovated and optimized in terms of administration method, portability and production process, and has significant competitive advantages and clinical application value. It is recommended to further conduct clinical research, improve product design and quality standards, and realize industrial application as soon as possible. In addition, an alternative is to dissolve creatine and sweetness indicator in pure water to prepare a solution, and then use a special inhalation device to deliver the solution.
[0025] In order to achieve the above object, the present invention adopts the following technical solutions:
[0026] An inhalable creatine powder inhaler, the creatine powder inhaler comprising creatine, a carrier, and a taste indicator;
[0027] In terms of weight percentage, the creatine accounts for 1-10%, the carrier accounts for 90-99%, and the taste indicator accounts for 0-1%;
[0028] The dosage form of the creatine powder inhaler is dry powder.
[0029] The inhalable creatine powder aerosol described above,
[0030] The creatine powder inhaler is composed of creatine, a carrier and a taste indicator;
[0031] In terms of weight percentage, the creatine accounts for 1-5%, the carrier accounts for 95-99%, and the taste indicator accounts for 0-0.5%.
[0032] The inhalable creatine powder aerosol described above,
[0033] The creatine powder inhaler is composed of creatine, a carrier and a taste indicator;
[0034] In terms of weight percentage, the creatine accounts for 2.7%, the carrier accounts for 97%, and the taste indicator accounts for 0.3%.
[0035] The inhalable creatine powder aerosol described above,
[0036] The creatine is anhydrous creatine, monohydrate creatine or creatine hydrochloride.
[0037] The inhalable creatine powder aerosol described above,
[0038] The carrier is lactose monohydrate, anhydrous lactose, mannitol, sucrose or trehalose.
[0039] The inhalable creatine powder aerosol described above,
[0040] The carrier is lactose monohydrate or mannitol.
[0041] The inhalable creatine powder aerosol described above,
[0042] The taste indicator is neotame, sucralose, aspartame, stevioside, licorice, disodium glycyrrhizinate, tripotassium glycyrrhizinate, erythritol, xylitol, sorbitol, mannitol, maltitol, isomalt, neomethyl hesperidin dihydrochalcone or hydrogenated starch hydrolysate.
[0043] The inhalable creatine powder aerosol described above,
[0044] The particle size of the creatine particles is D90<20μm;
[0045] The particle size of the carrier is 5 μm <D90<1000μm;
[0046] The particle size of the taste indicator is 5 μm <D90<500μm。
[0047] The inhalable creatine powder aerosol described above,
[0048] The particle size of the creatine particles is D90<5μm;
[0049] The particle size of the carrier is 50 μm <D90<300μm;
[0050] The particle size of the taste indicator is 15 μm <D90<100μm。
[0051] A method for preparing the inhalable creatine powder aerosol as described above comprises the following steps:
[0052] Grinding of creatine material: Use a fluidized bed airflow mill or an airflow mill to grind creatine to obtain creatine particles to increase the inhalable fraction of creatine and enhance lung absorption; in addition, creatine can be ground using a ball mill, a disc airflow mill, a hammer mill, a nail disc mill, or a fluidized bed airflow mill, preferably a disc airflow mill and a fluidized bed airflow mill.
[0053] Premixing of carrier and taste indicator: first, mix the carrier and taste indicator uniformly according to the proportion, and use a V-type mixer to mix for 5-20 minutes to obtain a premix;
[0054] Mixing creatine with the premix: repeatedly passing the obtained creatine particles and the obtained premix through the sieve of a rocking granulator to obtain a mixture, the mixing time is 10-30 minutes, and uniform mixing is ensured; in the mixing step, the material to be mixed is repeatedly passed through the sieve of a rocking granulator, and the particle size passing through the sieve is 100-1000 μm, preferably 200-500 μm, and at the same time, the number of times the material passes through the sieve is 5-100 times, preferably 10-60 times, and more preferably 20-40 times. In actual use, an intermediate value is selected.
[0055] Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
[0056] Beneficial effects of the present invention:
[0057] The inhalable creatine powder spray provided by the present invention adopts an inhalation administration method, and compared with existing oral creatine products, it has the advantages of smaller dosage and faster onset. Inhalation administration can quickly deliver the drug to the lungs, avoid the first-pass effect of the liver, achieve a blood drug concentration similar to oral administration at a lower dose, and the onset time is faster. The user of the inhalable creatine powder spray of the present invention has almost no perception of the product (only a slight sweetness indication), and better compliance. However, the flavor of existing oral creatine products is often poor, which affects the compliance of users. The inhalable creatine powder spray of the present invention is small in size, easy to carry, simple to use, and not affected by the use environment. However, existing creatine products are inconvenient to carry and need to be brewed when used. The method for preparing the inhalable creatine powder spray of the present invention uses simple equipment to repeatedly screen to achieve uniform mixing of low-content drugs and carriers, which is suitable for small batch production. Conventional low-content drug mixing usually requires expensive high-shear mixing equipment, which has certain requirements for production batches.
[0058] In summary, the inhalable creatine powder spray and the preparation method thereof provided by the present invention overcome many shortcomings of existing oral creatine products, have significant clinical application advantages and production process advantages, and provide a more convenient and effective choice for athletes and bodybuilders to supplement creatine. BRIEF DESCRIPTION OF THE DRAWINGS
[0059] Figure 1This is a flow chart of the preparation and application of the inhalable creatine powder aerosol of the present invention;
[0060] Figure 2 is a system schematic diagram of the inhaler of the present invention;
[0061] Figure 3 It is a schematic diagram of the structure of the inhaler of the present invention;
[0062] Figure 4 This is a test result diagram of implementation mode 5 of the present invention; in the diagram, MA is Mouthpiece Adapter, IP is Induction Port, PRE is Perseparator, Stage 1-7 represents 7 plates, and MOC is Micro Orifice Collector.
[0063] In the figure:
[0064] 100, connecting shell; 101, flow chamber; 102, air inlet; 103, suction chamber; 104, suction port; 105, capsule chamber; 106, storage port; 107, placement port; 108, first puncture needle; 109, second puncture needle. DETAILED DESCRIPTION
[0065] The present invention is described in more detail below in an exemplary manner.
[0066] Existing creatine nutritional supplements are usually taken orally, such as granules, tablets, etc. Oral administration has problems such as low bioavailability, large dosage, and poor taste. The common dosage of oral creatine is 3-5g per day, but due to the limited absorption of creatine in the gastrointestinal tract, the bioavailability of oral administration is low.
[0067] Compared with oral administration, inhalation administration can deliver drugs directly to the lungs, avoiding the first-pass effect of the liver. And because the lungs have a huge surface area (about 100m 2 ) and a rich capillary network, after inhalation administration, the drug can quickly enter the systemic circulation to exert its effect. Therefore, inhalation administration can usually effectively reduce the dosage, accelerate the onset of action, and improve patient compliance.
[0068] The inhalable creatine powder prepared by the present invention can achieve a blood drug concentration level similar to that of an oral dose of 3-5g at a dose of tens of micrograms (μg). Studies have shown that nasal administration of creatine can significantly increase the creatine level in the rat brain, indicating that inhalation administration can effectively improve the bioavailability of creatine.
[0069] In addition, the inhaled creatine prepared by the present invention also takes effect much faster than the oral form. Oral creatine usually takes several hours to reach the peak blood concentration, while inhaled creatine can take effect in a few minutes. This feature makes it very suitable for athletes and bodybuilders who need to quickly improve their body's explosive power.
[0070] In addition, the present invention also provides a simple, efficient and widely applicable mixing method for mixing inhalation preparation prescriptions with low drug content. Traditional high shear mixing equipment is expensive and has requirements for production batches, while the present invention uses a method of repeated screening of materials to achieve uniform mixing, with simple equipment and suitable for small-batch production such as laboratories. Specifically, the existing creatine product is taken orally, with a large dosage, and the present product is optimized for inhalation, with a smaller dosage and faster onset; the flavor of existing creatine products is often poor, and the user's compliance is poor. Due to the use of inhalation administration, the user has almost no perception of the product (only a little sweetness indication), and the compliance is better; the existing creatine products are inconvenient to carry and need to be brewed, while the present product is small in size, portable, and easy to use, and is not affected by the use environment; for the mixing of low-content drugs, it is usually necessary to use a high shear mixer for mixing, and the price of the equipment is high, and there are certain requirements for batches, while the present invention uses the principle of repeatedly screening the material to achieve the purpose of mixing, and the advantage is that the instrument used is simple and easy to obtain, the method is simple, and it is suitable for the mixing of small batches of materials.
[0071] Implementation 1
[0072] An inhalable creatine powder inhaler, wherein the creatine powder inhaler is composed of creatine, a carrier, and a taste indicator;
[0073] In terms of weight percentage, the creatine accounts for 1%, the carrier accounts for 98.9%, and the taste indicator accounts for 0.1%;
[0074] The dosage form of the creatine powder inhaler is dry powder.
[0075] The inhalable creatine powder aerosol described above,
[0076] The creatine is anhydrous creatine.
[0077] The inhalable creatine powder aerosol described above,
[0078] The carrier is lactose monohydrate.
[0079] The inhalable creatine powder aerosol described above,
[0080] The taste indicator is neotame.
[0081] The inhalable creatine powder aerosol described above,
[0082] The particle size of the creatine particles is D90=15 μm;
[0083] The particle size of the carrier is D90=800 μm;
[0084] The particle size of the taste indicator is D90=400 μm.
[0085] The preparation method of the inhalable creatine powder aerosol as described above, Figure 1 As shown, the following steps are included:
[0086] Grinding of creatine materials: Use a fluidized bed airflow mill to grind creatine into creatine particles to increase the inhalable fraction of creatine and enhance lung absorption;
[0087] Premixing of carrier and taste indicator: first, mix the carrier and taste indicator uniformly according to the proportion, and use a V-type mixer to mix for 5 minutes to obtain a premix;
[0088] Mixing creatine with the premix: repeatedly passing the obtained creatine granules and the obtained premix through a sieve of a swing granulator to obtain a mixture, with a mixing time of 30 minutes to ensure uniform mixing;
[0089] Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
[0090] Implementation 2
[0091] An inhalable creatine powder inhaler, wherein the creatine powder inhaler is composed of creatine, a carrier, and a taste indicator;
[0092] In terms of weight percentage, the creatine accounts for 10%, the carrier accounts for 90%, and the taste indicator accounts for 0%;
[0093] The dosage form of the creatine powder inhaler is dry powder.
[0094] The inhalable creatine powder aerosol described above,
[0095] The creatine is creatine monohydrate.
[0096] The inhalable creatine powder aerosol described above,
[0097] The carrier is anhydrous lactose.
[0098] The inhalable creatine powder aerosol described above,
[0099] The particle size of the creatine particles is D90=15 μm;
[0100] The particle size of the carrier is D90=600 μm.
[0101] The preparation method of the inhalable creatine powder aerosol as described above comprises the following steps:
[0102] Grinding of creatine materials: Use a jet mill to grind creatine into creatine particles to increase the inhalable fraction of creatine and enhance lung absorption;
[0103] Mixing creatine with the carrier: using a double-shaft paddle mixer, mixing the obtained creatine particles with the obtained carrier in proportion to obtain a mixture, and mixing for 10 minutes to ensure uniform mixing;
[0104] Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
[0105] Implementation 3
[0106] An inhalable creatine powder inhaler, wherein the creatine powder inhaler is composed of creatine, a carrier, and a taste indicator;
[0107] In terms of weight percentage, the creatine accounts for 1%, the carrier accounts for 99%, and the taste indicator accounts for 0%;
[0108] The dosage form of the creatine powder inhaler is dry powder.
[0109] The inhalable creatine powder aerosol described above,
[0110] The creatine is creatine hydrochloride.
[0111] The inhalable creatine powder aerosol described above,
[0112] The carrier is mannitol.
[0113] The inhalable creatine powder aerosol described above,
[0114] The particle size of the creatine particles is D90=7 μm;
[0115] The particle size of the carrier is D90=400 μm.
[0116] The preparation method of the inhalable creatine powder aerosol as described above comprises the following steps:
[0117] Grinding of creatine materials: Use a fluidized bed airflow mill to grind creatine into creatine particles to increase the inhalable fraction of creatine and enhance lung absorption;
[0118] Mixing creatine with the carrier: using a double-shaft paddle mixer, mixing the obtained creatine particles with the obtained carrier in proportion to obtain a mixture, the mixing time is 25 minutes, and ensuring uniform mixing;
[0119] Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
[0120] Implementation 4
[0121] An inhalable creatine powder inhaler, wherein the creatine powder inhaler is composed of creatine, a carrier, and a taste indicator;
[0122] In terms of weight percentage, the creatine accounts for 5%, the carrier accounts for 94%, and the taste indicator accounts for 1%;
[0123] The dosage form of the creatine powder inhaler is dry powder.
[0124] The inhalable creatine powder aerosol described above,
[0125] The creatine is anhydrous creatine.
[0126] The inhalable creatine powder aerosol described above,
[0127] The carrier is sucrose.
[0128] The inhalable creatine powder aerosol described above,
[0129] The taste indicator is tripotassium glycyrrhizinate.
[0130] The inhalable creatine powder aerosol described above,
[0131] The particle size of the creatine particles is D90=5 μm;
[0132] The particle size of the carrier is D90=300 μm;
[0133] The particle size of the taste indicator is D90=300 μm.
[0134] The preparation method of the inhalable creatine powder aerosol as described above comprises the following steps:
[0135] Grinding of creatine materials: Use a jet mill to grind creatine into creatine particles to increase the inhalable fraction of creatine and enhance lung absorption;
[0136] Premixing of carrier and taste indicator: First, mix the carrier and taste indicator evenly according to the proportion, and use a V-type mixer to mix for 18 minutes to obtain a premix;
[0137] Mixing creatine with the premix: repeatedly passing the obtained creatine granules and the obtained premix through the sieve of the swing granulator to obtain a mixture, and the mixing time is 15 minutes to ensure uniform mixing;
[0138] Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
[0139] Implementation 5
[0140] An inhalable creatine powder inhaler, wherein the creatine powder inhaler is composed of creatine, a carrier, and a taste indicator;
[0141] In terms of weight percentage, the creatine accounts for 2.7%, the carrier accounts for 97%, and the taste indicator accounts for 0.3%;
[0142] The dosage form of the creatine powder inhaler is dry powder.
[0143] The inhalable creatine powder aerosol described above,
[0144] The creatine is creatine monohydrate.
[0145] The inhalable creatine powder aerosol described above,
[0146] The carrier is trehalose.
[0147] The inhalable creatine powder aerosol described above,
[0148] The carrier is mannitol.
[0149] The inhalable creatine powder aerosol described above,
[0150] The taste indicator is sorbitol.
[0151] The inhalable creatine powder aerosol described above,
[0152] The particle size of the creatine particles is D90=3 μm;
[0153] The particle size of the carrier is D90=100 μm;
[0154] The particle size of the taste indicator is D90=50 μm.
[0155] The preparation method of the inhalable creatine powder aerosol as described above comprises the following steps:
[0156] Grinding of creatine materials: Use a fluidized bed airflow mill to grind creatine into creatine particles to increase the inhalable fraction of creatine and enhance lung absorption;
[0157] Premixing of carrier and taste indicator: First, mix the carrier and taste indicator evenly according to the proportion, and use a V-type mixer to mix for 12 minutes to obtain a premix;
[0158] Mixing creatine with the premix: repeatedly passing the obtained creatine granules and the obtained premix through the sieve of the swing granulator to obtain a mixture, and the mixing time is 22 minutes to ensure uniform mixing;
[0159] Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
[0160] Test plan
[0161] Administration: Oral inhalation.
[0162] like Figure 2 and Figure 3 As shown, the product is inhaled by the user through an inhaler (capsule inhalation device, reference patent publication number: CN118079156A). Specifically, the capsule inhalation device includes:
[0163] Connecting housing 100;
[0164] A flow bin 101 is provided on the connection housing 100, an air inlet 102 is provided on one side of the flow bin 101, and suction bins 103 connected to the flow bin 101 are connected to both sides of the flow bin 101, and the two suction bins 103 extend to the top of the flow bin 101 and are connected to form an air inlet 104;
[0165] The capsule compartment 105 is slidably connected to the connecting shell 100. A storage opening 106 is provided on one side of the capsule compartment 105. A placement opening 107 communicating with the storage opening 106 is provided on one side of the connecting shell 100.
[0166] A first puncture needle 108 is disposed in the capsule compartment 105 and faces the capsule, and the bottom height of the first puncture needle 108 is higher than the placement port 106;
[0167] The second puncture needle 109 is disposed in the connecting housing 100 and faces the capsule compartment 105;
[0168] The capsule withdrawing component is disposed between the flow chamber 101 and the connecting shell 100, and is used to withdraw the punctured capsule into the flow chamber 101 when the capsule chamber 105 is moved downward to a preset position and reset upward to the preset position;
[0169] By setting the capsule bin 105, when in use, the user can move the position of the capsule bin 105 so that the placement port 106 on the capsule bin 105 overlaps and is connected with the placement port 107 on the connecting shell 100, and the capsule is placed in the capsule bin 105 from the placement port 107 and the placement port 106. The top of the capsule will contact the first puncture needle 108, and the capsule bin 105 is moved downward. The capsule bin 105 drives the capsule therein to move downward along the path of the connecting shell 100 close to the second puncture needle 109. When the capsule bin 105 moves to a preset position, it contacts the second puncture needle 109. The capsule bin 105 is continued to be moved. The capsule bin 105 can limit the capsule therein. As the pressure between the capsule and the second puncture needle 109 increases, the second puncture needle 109 will gradually puncture the capsule. After that, the capsule bin 105 is reset upward. When the capsule bin 105 is moved downward to the preset position and reset upward to the preset position, the capsule withdrawing component can withdraw the punctured capsule into the flow bin 101. At this time, the user can inhale from the air inlet 104 formed by the inhalation bin 103, and the external gas can enter the flow bin 101 from the air inlet 102 on the flow bin 101 and pass through the punctured capsule. With the flow of gas, the medicine powder in the capsule can be inhaled. The method of puncturing the medicine core is simple, which avoids the fragments generated when the medicine core is punctured and inhaled into the human body together with the medicine. The device can be reused many times. After placing the capsule in the capsule bin 105, the user only needs to simply press the capsule bin 105 to complete the work of puncturing the capsule and unloading the medicine. The user operation is simple.
[0170] like Figure 4 As shown in Table 1, the prescription in Embodiment 5 was loaded into No. 3 HPMC capsules (Suzhou Capsule Co., Ltd.), with a loading of 20 ± 1 mg per capsule, and the distribution of the mist particles of inhaled creatine was measured at flow rates of 30, 60 and 90 L / min using NGI (cascade impactor, Copley Scientific Limited, UK), with reference to the Chinese Pharmacopoeia "0951 Method for Determination of Aerodynamic Properties of Fine Particles of Inhaled Preparations". These results show that the inhaled creatine powder aerosol can produce a certain proportion of fine particles at different flow rates, and as the flow rate increases, the proportion and dosage of fine particles are increased. This shows that the preparation can effectively deliver creatine particles to the lungs at different inhalation intensities, especially at higher flow rates. This performance is very important for ensuring that the drug can effectively reach the target site, and helps to improve the efficiency and efficacy of inhalation administration.
[0171] Table 1 NGI test results of creatine particles at different flow rates (n=3)
[0172] Flow rate (L / min) FPF(%) FPM(μg) 30 41.05±0.39 221.67±2.09 60 57.63±6.73 331.20±36.36 90 63.40±4.93 342.34±26.64
[0173] At present, the innovation of creatine products is mainly reflected in the following aspects:
[0174] Improved portability and ease of use
[0175] Traditional creatine products are mostly bulk powders, which need to be weighed and brewed when used, which is not convenient. Some new products, such as WILD FIELD HEALTH's small bags of creatine powder, each bag contains 4g, which only requires a small amount of product to be carried and brewed directly, greatly improving portability.
[0176] Notland's creatine tablets further eliminate the brewing process. Each tablet contains 500 mg of creatine, making it more convenient to take and easier to carry.
[0177] Diversification of dosage forms
[0178] In addition to traditional powders and tablets, some companies have also developed creatine drinks. Coca-Cola has disclosed a patent for a creatine drink formula with good stability. After being stored at 5°C for 3 months, the creatine content can still remain above 90%, providing consumers with more choices.
[0179] Optimizing taste
[0180] The early creatine powder had a poor taste, and some products, such as Combite's creatine powder, added flavors and sweeteners to improve the taste. New dosage forms such as sachets, tablets, and beverages also have more advantages in taste.
[0181] Precise supplementation
[0182] The dosage of creatine powder in small bags is fixed, and the content of each tablet is clear, which can supplement creatine more accurately and avoid excessive intake.
[0183] In short, the innovation of creatine products mainly focuses on portability, taste, and dosage form diversity to meet the increasing demand of consumers. In the future, further optimization can be made in these directions, such as developing new dosage forms such as oral instant granules and jellies, combining them with nutrients such as vitamins, and developing a variety of flavor options to enhance product competitiveness.
[0184] The applicant declares that the present invention is explained by the above embodiments, but the present invention is not limited to the above, that is, it does not mean that the present invention must rely on the above to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of the raw materials selected by the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
Claims
1. An inhalable creatine powder spray, characterized in that: The creatine powder inhaler is composed of creatine, a carrier and a taste indicator; In terms of weight percentage, the creatine accounts for 1-10%, the carrier accounts for 90-99%, and the taste indicator accounts for 0-1%; The dosage form of the creatine powder inhaler is dry powder.
2. The inhalable creatine powder aerosol according to claim 1, characterized in that: The creatine powder inhaler is composed of creatine, a carrier and a taste indicator; In terms of weight percentage, the creatine accounts for 1-5%, the carrier accounts for 95-99%, and the taste indicator accounts for 0-0.5%.
3. The inhalable creatine powder aerosol according to claim 2, characterized in that: The creatine powder inhaler is composed of creatine, a carrier and a taste indicator; In terms of weight percentage, the creatine accounts for 2.7%, the carrier accounts for 97%, and the taste indicator accounts for 0.3%.
4. The inhalable creatine powder aerosol according to claim 1, characterized in that: The creatine is anhydrous creatine, monohydrate creatine or creatine hydrochloride.
5. The inhalable creatine powder aerosol according to claim 1, characterized in that: The carrier is lactose monohydrate, anhydrous lactose, mannitol, sucrose or trehalose.
6. The inhalable creatine powder aerosol according to claim 5, characterized in that: The carrier is lactose monohydrate or mannitol.
7. The inhalable creatine powder aerosol according to claim 1, characterized in that: The taste indicator is neotame, sucralose, aspartame, stevioside, licorice, disodium glycyrrhizinate, tripotassium glycyrrhizinate, erythritol, xylitol, sorbitol, mannitol, maltitol, isomalt, neomethyl hesperidin dihydrochalcone or hydrogenated starch hydrolysate.
8. The inhalable creatine powder aerosol according to claim 1, characterized in that: The particle size of the creatine particles is D90<20μm; The particle size of the carrier is 5 μm <D90<1000μm; The particle size of the taste indicator is 5 μm <D90<500μm。 9. The inhalable creatine powder aerosol according to claim 8, characterized in that: The particle size of the creatine particles is D90<5μm; The particle size of the carrier is 50 μm <D90<300μm; The particle size of the taste indicator is 15 μm <D90<100μm。 10. A method for preparing the inhalable creatine powder aerosol according to claim 1, characterized in that: The following steps are involved: Grinding of creatine materials: Use a fluidized bed airflow mill or airflow mill to grind creatine into creatine particles to reduce the particle size, increase the inhalable fraction of creatine, and enhance lung absorption; Premixing of carrier and taste indicator: first, mix the carrier and taste indicator evenly according to the proportion, and use a V-type mixer to mix for 5-20 minutes to obtain a premix; Mixing creatine with the premix: repeatedly passing the obtained creatine granules and the obtained premix through a sieve of a swing granulator to obtain a mixture, with a mixing time of 10-30 minutes to ensure uniform mixing; Filling: The mixture obtained in the previous step is filled into capsules to obtain the product.
Citation Information
Patent Citations
Novel capsule suction device
CN118079156A
